Friday, 14 June 2024

How are Industries in Probiotics Market Leaping Ahead?

 Oasis of Opportunities in Probiotics

Cultural and economic shifts are shaping the probiotics market, fostering dietary supplement and food and beverage industries. Consumer trends allude to the rising prominence of probiotics, which offer a slew of health upsides, including digestive and immune health and advancements in weight management. Brands are zeroing in on additional probiotic health benefits to keep up with the soaring consumer demand. A few studies have claimed that certain strains of probiotic bacteria might prevent the common cold and influenza and/or reduce the duration of the disease. The strong link of probiotics with gut health and immunity has steered a wave of trends in digestive health.

Notably, products with probiotics claims, such as frozen yogurt, fermented drinks, cereals, snack bars, infant formula and dairy-based ice creams, have gained ground. In January 2024, the International Food Information Council (IFIC) inferred that a Consumer Insights on Gut Health and Probiotics Survey—conducted by IFIC—found that one in four Americans (those who try to consume probiotics) stated they commonly seek them in wellness drinks.

Surging demand for microbiome-nurturing ingredients has prompted manufacturers and other leaders to emphasize women’s health and cognitive health. Prevailing trends indicate the global probiotics market could reach USD 220.14 billion in revenue in 2030. The growth trajectory is a major indicator for stakeholders as to where the industry is heading.

What are the strategies that can help incumbents and startups leap the competition and keep abreast of the trends?

Bacteria-Based Ingredient Braces for Microbiome Trend

The gut microbiome has become the trailblazer as it is highly attributed to weight management and skin and cognitive health. A healthy gut microbiome has the innate ability to minimize inflammation and bolster immunity, encouraging food and beverage, pharmaceutical and cosmetic industries to explore opportunities. To illustrate, in April 2023, the U.S. FDA approved the first oral microbiome to be used as a therapeutic. The agency gave the nod to Seres Therapeutics’ live microbiome capsule Vowst; the product will reportedly be co-commercialized by Nestle.

As problems with the gut microbiome have been associated with a host of diseases, such as cancer, diabetes and obesity, researchers are expected to focus on next-generation probiotics (NGPs). Studies suggest NGPs—regulating the gut microbiome—can modulate inflammatory pathways, minimize oxidative stress and prevent neurodegenerative and viral diseases.

Opportunities and Challenges Redefine Dietary Supplements

Millennials and the Gen Z population are pinning hope on food supplements, specialty supplements, nutritional supplements and infant formula products. Probiotic supplements have gained ground to boost digestive and immune health. Pervasive obesity, high blood pressure and a sedentary lifestyle have put the spotlight on dietary supplements. In essence, probiotic strains— spore-forming probiotic bacteria—have become sought-after due to their stability. Lately, Americans are counting on probiotic dietary supplements; so much so that customized products are gradually gaining traction.

Convenient dietary products, such as capsules and chewable gummies, have become prevalent, suggesting the prospect of dietary supplements. However, in October 2023, the U.S. FDA raised an alarm bell regarding the sale of probiotic products for use in hospitalized preterm infants. The organization inferred that the product was an adulterated dietary supplement (under the Federal Food, Drug, and Cosmetic Act) as B. infantis (Bb-02) and S. thermophilus (TH-4) failed to meet the applicable safety requirements.

Future Outlook: an Emphasis on Mental Health

Soaring commercialization of probiotics alludes to the trend for functional foods and chewable tablets. Products containing natural probiotics, including naturally fermented yogurts and kimchi, are likely to gain prominence. Besides, Probiotics-enriched chocolates, snack bars, kombucha, Tempeh, Natto, Miso, Sauerkraut and kefir could be sought by millennials and Gen Z customers.

Probiotics could also boost mental health; researchers are investigating the potential of psychobiotics as a cure-all for mental health problems. A 2022 randomized controlled trial in Translational Psychiatry found that a high-dose probiotic with eight different bacteria strains helped reduce depression symptoms. Psychobiotics can also minimize the risk of Alzheimer’s disease and heart disease. The next half-decade could provide revenue-generating opportunities for probiotics manufacturers and suppliers.

How Clinical Trials Help Diagnose the Future of Medicine?

 The growing prevalence of chronic diseases and the incidence of novel diseases is expected to boost the clinical trials market. According to the World Heart Report 2023, over half a billion people worldwide are affected by Cardiovascular Diseases (CVDs), which caused over 20.5 million deaths in 2021. Furthermore, according to the Parkinson’s Foundation, approximately 1 million individuals in the U.S. currently suffer from Parkinson's Disease (PD), which is projected to increase to over 1.2 million by 2030.

The prevalence of rare or orphan diseases has garnered attention in recent years, necessitating specialized clinical trials. As diseases become more varied and complex, there is a heightened demand for specialized expertise in clinical trial design, patient recruitment, and data analysis. Trial sponsors seek experts capable of navigating the intricacies of diverse diseases. Thus, the aforementioned factors are expected to drive the market demand.

From Firsts to Finals: The Four Phases

  • Phase I: Phase I clinical trials are the first stage of human testing for a new medical intervention. They focus on evaluating its safety, determining the appropriate dosage, and collecting initial data on how the body interacts with the intervention.
  • Phase II: Phase II clinical trial is a controlled study conducted on a relatively larger group of patients to assess the safety and efficacy of a new medical intervention, such as a drug or treatment.
  • Phase III: A Phase III clinical trial involves a large-scale and rigorously controlled study conducted to confirm and further evaluate the safety and effectiveness of a medical intervention identified in Phase II.
  • Phase IV: A Phase IV clinical trial, also known as post-marketing surveillance, occurs after a medical product has received regulatory approval.

Top Trends Streamlining Clinical Trials:

  • Rising Demand for Personalized Medicine: Numerous companies are focusing on the development of targeted therapies to cater to specific genetic diseases. Clinical trials are pivotal in validating these therapies, potentially leading to smaller, more specialized markets. Furthermore, several regulatory authorities offer flexibility in trial designs, with real-world evidence and favorable regulatory pathways for smaller patient populations, positively influencing market growth.
  • Technological Advancements: The growing adoption of decentralized clinical trials and telemedicine in clinical trials offers several advantages, which are expected to drive the overall potential of the industry. Moreover, the integration of remote monitoring technology enables continuous patient data collection outside clinical settings. This real-time data improves trial accuracy, enhances patient engagement, and allows more comprehensive insights into patient health.
  • Research & Development Activities: Collaborations between biopharmaceutical companies and CROs are expected to impact the industry positively. Contract research organizations have seen a major boost owing to rising R&D expenditures and pharmaceutical companies’ increasing focus on cost containment. Several biopharmaceutical and medical device companies are outsourcing their clinical trials to CROs to reduce product development time and cost.

The Final Diagnosis:

Clinical trials might seem like an intricate world of complex processes but they are the bridge between ground-breaking discoveries and life-saving treatments. By participating in such trials, individuals can contribute to medical progress, thereby paving the way for a healthier future. Even the smallest contribution can help make a world of great difference!

From Lab to Life: Analysing Top 5 Trends in Clinical Diagnostics

 The clinical diagnostics market, like many other businesses, is entering the Industry 4.0 revolution. The advent of digitalization, automation, and robotization has helped develop highly flexible smart laboratories. These labs can manage both high-volume/routine analyses and highly customized analyses at reasonable prices. Clinical laboratories are required to have exceptional flexibility to adapt quickly to persistent shifts and unpredictable new environments.

Mentioned below are the 5 key trends that are helping the clinical diagnostics industry survive in a dynamic environment:

  1. Integration of Automation Technologies in Genomics

Over the years, the accuracy of genome sequencing has radically improved. Furthermore, sequencing and library preparation platforms are now more affordable than ever before, both of which are making the technology more extensively accessible. Advancements in data analytics have also enhanced the study of genomics by revealing unknown correlations, hidden patterns, and other insights, specifically when investigating large-scale data sets.

At the core of this advancement are automation technologies that facilitate much higher flexibility, throughputs, and low-cost solutions. Furthermore, reduced costs of DNA sequencing and genotyping have made DNA testing widely available to end-users. This has resulted in a robust growth rate in the number of consumers embracing genetic testing. An enormous number of consumers consent to making their samples available for research. Conclusively, the overall volume of generated biological data is exponentially growing.

  1. Rise of Patient-centric Approaches

The changing consumer expectations have necessitated the adoption of patient-centric approaches in healthcare settings. The recent years have seen a developing interest in personalized training and diet programs as well as customized cosmetic products and procedures. While medicine has revolved around standardized procedures based on a statistically average non-existent person, automation of clinical diagnostics has implied that medical treatment can be tailor-made as per an individual’s genetic considerations.

  1. Emerging At-home Diagnostics Point-of-care Testing Solutions

Advancements in clinical diagnostics technology have enabled rapid testing in patients’ homes. This helps facilitate enhanced disease monitoring, diagnosis, and management. A key advantage of digitalization in at-home and point-of-care diagnostics is the convenience of the testing procedure and the storage and analysis of results in a protected digital environment that healthcare providers can access.

  1. AI-driven Medical Imaging

One of the primary benefits of AI in medical imaging is its ability to improve the efficiency and accuracy of disease diagnosis. Artificial intelligence solutions enable healthcare professionals to determine diseases with the help of optimized medical images. Healthcare professionals can precisely identify specific structures, detect abnormalities, and predict disease outcomes for enhanced clinical diagnostics.

  1. Real-time diagnostics

Wearable biosensors, including watches, glasses, contact lenses, clothing, bandages, rings, and ingestible and implantable devices, collect physical health information in the form of blood pressure, heart rate, respiratory rate, skin temperature, and body motion. Compared to conventional diagnostic tests that only capture a particular parameter, real-time diagnostics deliver more robust and wide-ranging data analysis for clinical decision-making. They facilitate continuous monitoring, which provides instant feedback on irregularities and can be used to track a patient’s overall health and well-being.

What to Expect?

These trends bring new thrilling possibilities for the clinical diagnostics industry; however, they also present new challenges. These challenges include concerns regarding safety issues, patient integrity and risks associated with an ever-changing environment. With the fourth industrial revolution, relentless transformation is becoming the new normal. To tap into new business opportunities, clinical laboratories need to modify their operations and processes on a continual basis. There is no gold standard solution to address these challenges. Instead, those who are able to adapt to a dynamic environment will be the winners of the game.

Thursday, 13 June 2024

Biopharmaceuticals Contract Manufacturing Market is Anticipated to Register 5.2% CAGR through 2030

 

Biopharmaceuticals Contract Manufacturing Market Growth & Trends

The global biopharmaceuticals contract manufacturing market size is expected to reach USD 27.3 billion by 2030, growing at a CAGR of 5.2% from 2022 to 2030, according to a new report by Grand View Research, Inc. Growing biopharmaceutical pipeline and lack of adequate manufacturing capabilities are two key factors that are driving partnership between large molecule manufacturers and Contract Manufacturing Organizations (CMOs). Contract manufacturers are engaged in broadening their service portfolio to meet the companies' demands with respect to regulatory standards and new services. The pandemic has, however, also had some negative knock-on effects as budgets and resources are diverted to “COVID products” at the expense of other biologics projects in development for other therapeutic areas.

The reliance of companies on CMOs for the production of biologics and biosimilars is expected to rise during the forecast period as a consequence of changes adopted by the CMOs. This is evident through growing investment in collaborations of companies with CMOs as well as continuous efforts taken up for expanding the service portfolio. The supply chain of biopharmaceuticals remained robust and was largely unaffected worldwide during the coronavirus outburst. Also, biopharmaceutical contract manufacturers are observing increased demand related to COVID-19 vaccine and therapeutics. Thus, the future holds numerous opportunities for the market. For instance, in 2020, AstraZeneca and Oxford Biomedica signed a one-year clinical and commercial supply agreement for the manufacturing of AstraZeneca’s COVID-19 vaccine candidate, AZD1222.

The future growth of the market is highly dependent on the promising opportunities offered by the biopharmaceutical industry, bioprocessing industry, and contract service industry. Expansion of fill-and-finish services and increasing robustness of venture capital investments for the life science sector are two important opportunities that are anticipated to drive the market. For instance, in 2019, Shanghai HaiHe Biopharma Co. Ltd. raised USD 146.6 million as venture capital for its large cancer drug portfolio, which it shall utilize along with its outsourcing partner Zhejiang Jiuzhou Pharmaceutical Co., Ltd. 

Request a free sample copy or view the report summary: Biopharmaceuticals Contract Manufacturing Market Report

Biopharmaceuticals Contract Manufacturing Market Report Highlights

  • Mammalian-based biopharmaceutical contract manufacturing captured the largest market share about 58% in 2021 owing to the high penetration of mammalian expression systems for biologics development
  • Out of all the services offered in this market, process development contributed to the largest share of 33% in 2021, owing to high capital investment, especially in downstream process
  • Biologics contract manufacturing dominated its counterpart segment owing to higher demand for biologics production. However, the biosimilar segment is growing with a lucrative CAGR of 8.3% due to cost-saving advantages associated with biosimilars development
  • The presence of an effective regulatory framework for biologics development in the U.S. has resulted in a large share of the North America market of 34.0% in 2021
  • However, Asia Pacific is expected to emerge as the fastest-growing regional market with a CAGR of 5.8% from 2022 to 2030, owing to developing economies such as India and China incorporating developments to sustain the competition

Access Press Release@ https://www.grandviewresearch.com/press-release/global-biopharmaceuticals-contract-manufacturing-market

Biopharmaceuticals Contract Manufacturing Market Segmentation

Grand View Research has segmented the global biopharmaceuticals contract manufacturing market based on source, service, product, therapeutic area and region: 

Biopharmaceuticals Contract Manufacturing Source Outlook (Revenue, USD Million, 2017 - 2030)

  • Mammalian
  • Non-mammalian

Biopharmaceuticals Contract Manufacturing Service Outlook (Revenue, USD Million, 2017 - 2030)

  • Process Development
    • Downstream
    • Upstream
  • Fill & Finish Operations
  • Analytical & QC studies
  • Packaging

Biopharmaceuticals Contract Manufacturing Product Outlook (Revenue, USD Million, 2017 - 2030)

  • Biologics
    • Monoclonal antibodies (MABs)
    • Recombinant Proteins
    • Vaccines
    • Antisense, RNAi, & Molecular Therapy
    • Others
  • Biosimilars

Biopharmaceuticals Contract Manufacturing Therapeutic Area Outlook (Revenue, USD Million, 2017 - 2030)

  • Oncology
  • Autoimmune Diseases
  • Metabolic Diseases
  • Cardiovascular Diseases
  • Neurology
  • Infectious Diseases
  • Others

Biopharmaceuticals Contract Manufacturing Regional Outlook (Revenue, USD Million, 2017 - 2030)

  • North America
    • US.
    • Canada
  • Europe
    • UK 
    • Germany
    • France
    • Italy

Spain

  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Colombia
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia

UAE

List of Key Players in Biopharmaceuticals Contract Manufacturing Market

  • Boehringer Ingelheim GmbH
  • Lonza
  • Inno Biologics Sdn Bhd
  • Rentschler Biotechnologie GmbH
  • JRS PHARMA
  • AGC Biologics
  • ProBioGen
  • FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
  • Toyobo Co. Ltd.
  • Samsung BioLogics
  • Thermo Fisher Scientific, Inc.
  • Binex Co., Ltd.
  • WuXi Biologics
  • AbbVie, Inc.
  • Novartis AG
  • ADMA Biologics, Inc.
  • Catalent, Inc
  • Cambrex Corporation
  • Pfizer Inc.
  • Siegfried Holding AG

Explore Horizon, the world's most expansive market research database

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Global 5G Chipset Market to Register Stable Expansion During 2023 – 2030: Grand View Research Inc.

 5G Chipset Market Growth & Trends

The global 5G chipset market size is estimated to reach USD 143.69 billion by 2030, exhibiting a CAGR of 20.3% from 2023 to 2030, according to a new study by Grand View Research, Inc. With the increasing demand for 5G-enabled devices, there is a growing need for more powerful and efficient 5G chipsets that can support these devices. To improve performance and efficiency, many chipsets are being designed with built-in Artificial Intelligence (AI) capabilities, which allow devices to process data more quickly and accurately and make more intelligent decisions.

Additionally, there is an increasing focus on the development of specialized 5G chipsets for specific use cases, such as IoT devices, automotive applications, and virtual and augmented reality applications, which bodes well for the growth of the market over the coming years. The rising demand for high-speed internet is a major driving force behind the growth of the market. With the increasing popularity of bandwidth-intensive applications such as high-quality video streaming, virtual and augmented reality, and cloud gaming, there is a need for faster and more reliable internet connectivity.

The 5G network is designed to provide significantly faster download and upload speeds, lower latency, and greater capacity than previous generations of wireless networks. As a result, there is a growing need for 5G chipsets that can enable high-speed internet connectivity for a wide range of devices, including smartphones, laptops, IoT devices, and more.

With the rollout of 5G networks in many parts of the world, consumers are increasingly looking for devices that can take advantage of the new technology. 5G smartphones offer faster download and upload speeds, lower latency, and greater capacity than previous generations of smartphones, allowing users to enjoy faster and more reliable internet connectivity. As a result, there is a growing need for 5G chipsets that can power these devices, enabling them to provide the high-speed connectivity that users demand.

The COVID-19 pandemic increased the demand for remote work and online education, which in turn led to a surge in demand for devices that can provide fast and reliable internet connectivity. This created an opportunity for the market, as 5G technology is designed to provide faster and more reliable connectivity than previous generations of wireless networks. As a result, there was a significant increase in demand for 5G-enabled devices, including smartphones, laptops, and IoT devices.

Request a free sample copy or view report summary: 5G Chipset Market Report

5G Chipset Market Report Highlights

  • The RFICs segment dominated the market in 2022. The rising complexity of smartphones, which necessitates the use of additional RF transceiver ICs to support numerous antennas for features such as 4G/5G connection, Wi-Fi, Bluetooth, GPS, and NFC, is a major factor driving the segment growth
  • The Sub-6 GHz segment dominated the market in 2022. Increasing use of Sub-6 GHz technologies to provide comprehensive coverage in urban and rural regions, since these frequency bands offer more range and penetration than higher mmWave bands, is a primary factor driving the segment growth
  • The 7 nm segment dominated the market in 2022. The increasing use of the 7 nm technology node in chip design, which offers lower power consumption, greater switching performance, and higher density, is a primary factor driving the segment growth
  • The smartphones segment dominated the market in 2022. The segment's growth is mostly attributed to rising customer demand for mobile connection that is both quicker and more dependable
  • The IT & Telecommunication segment dominated the market in 2022. Significant factors influencing the segment growth include major manufacturers' extensive efforts in developing 5G chipset modules for telecom base stations, and other communication equipment’s
  • The Asia Pacific region dominated the market in 2022 owing to This is rising demand in in high-speed connection by consumers and the growing usage of modern technologies such as IoT, AI, and cloud computing 

Access Press Release@ https://www.grandviewresearch.com/press-release/global-5g-chipset-market

5G Chipset Market Segmentation

Grand View Research has segmented the global 5G chipset market based on type, operating frequency, processing node type, deployment type, vertical, and region:

5G Chipset Type Outlook (Revenue, USD Million, 2019 - 2030)

  • Modems
  • RFICs
    • RF Transceivers
    • RF FE
  • Others

5G Chipset Operating Frequency Outlook (Revenue, USD Million, 2019 - 2030)

  • Sub-6 GHz
  • 24-39 Ghz
  • Above 39 Ghz

5G Chipset Processing Node Type Outlook (Revenue, USD Million, 2019 - 2030)

  • 7 nm
  • 10 nm
  • Others

5G Chipset Deployment Type Outlook (Revenue, USD Million, 2019 - 2030)

  • Telecom Base Station Equipment
  • Smartphones/Tablets
    • Single-mode
      • Standalone
      • Non-standalone
    • Multi-mode
  • Connected Vehicles
    • Single-mode
      • Standalone
      • Non-standalone
    • Multi-mode
  • Connected Devices
    • Single-mode
      • Standalone
      • Non-standalone
    • Multi-mode
  • Broadband Access Gateway Devices
    • Single-mode
      • Standalone
      • Non-standalone
    • Multi-mode
  • Others
    • Single-mode
      • Standalone
      • Non-standalone
    • Multi-mode

5G Chipset Vertical Outlook (Revenue, USD Million, 2019 - 2030)

  • Manufacturing
  • Energy & Utilities
  • Media & Entertainment
  • IT & Telecom
  • Transportation & Logistics
  • Healthcare
  • Others

5G Chipset Regional Outlook (Revenue, USD Million, 2019 - 2030)

  • North America
    • US.
    • Canada
  • Europe
    • UK
    • Germany
    • Sweden
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
  • MEA (Middle East & Africa)
    • Kingdom of Saudi Arabia (KSA)
    • UAE
    • South Africa

List of Key Players in the 5G Chipset Market

  • Huawei Technologies, Inc
  • MediaTek Inc
  • Intel Corporation
  • Samsung
  • Infineon Technologies AG
  • Qualcomm Technologies, Inc
  • Unisoc Communications Inc.
  • Qorvo, Inc.
  • Anokiwave, Inc
  • Xilinx

Explore Horizon, the world's most expansive market research database

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Potash Market To Hold a High Potential for Growth by 2032: Grand View Research Inc.

 Potash Market Growth & Trends

The global potash market size is expected to reach USD 93.50 billion by 2032, growing at a CAGR of 4.9% from 2023 to 2032, according to a new study by Grand View Research, Inc. This is attributed to the increasing demand for food and efficient usage of agricultural land. As consumers seek healthier options, there has been a surge in demand for high-value crops like fruits, vegetables, and specialty crops, boosting the demand for potash. Furthermore, the adoption of precision agriculture techniques has become increasingly prevalent in recent years. Precision agriculture involves using advanced technologies and data-driven approaches, such as soil testing and targeted nutrient management, to make informed decisions about fertilizer application.

Farmers are embracing precise and site-specific methods for applying fertilizers, based on field variability and crop requirements. This trend makes way for optimized resource utilization, improved crop performance, and enhanced overall efficiency in agricultural practices. Consequently, adopting precision agriculture methods has contributed to the rising product demand as farmers strive to maximize crop yields and optimize nutrient management. Changing dietary preferences, growing consumer awareness, and adoption of precision agriculture techniques have significantly impacted the market growth. The increased demand for high-value crops and the emphasis on optimizing crop productivity and quality have fueled the product demand as an essential nutrient.

These trends underscore the product’s importance in supporting sustainable and efficient agricultural practices while meeting the evolving needs of modern consumers. However, price volatility remains a significant factor influenced by production capacities, global demand fluctuations, and currency exchange rates. In addition, supply chain constraints, including transportation and logistics challenges, can impact the product availability and pricing. These factors present obstacles to market growth and present challenges to industry players while meeting the evolving demands. Asia Pacific will emerge as the fastest-growing region at a CAGR of 5.7% from 2023 to 2032 due to high population, land fertility, increased demand for food grains, and effective use of land through fertilizer.

Request a free sample copy or view report summary: Potash Market Report

Potash Market Report Highlights

  • Potassium chloride is estimated to emerge as the fastest-growing application segment with a CAGR of 5.2% from 2023 to 2032
  • The demand for this commodity has grown substantially in recent years due to the significant increase in agricultural activities
  • The agriculture segment is estimated to register the fastest CAGR of 5.1% from 2023 to 2032
  • Key players in the industry are involved in broadening their product portfolio and global presence.
  • In September 2020, the German potash and salt mining company, K+S, agreed to sell its America’s salt business to Stone Canyon Industries Holdings for approximately $3.2 billion
  • Nutrien Ltd., one of the world's largest potash producers, announced in April 2021 that it has acquired Israeli specialty plant nutrient supplier, Agri body Technologies

Access Press Release@ https://www.grandviewresearch.com/press-release/global-potash-market

Potash Market Segmentation

Grand View Research has segmented the global potash market based on product, end-use, and region:

Potash Product Outlook (Volume, Tons; Revenue, USD Million, 2018 - 2032)

  • Potassium Chloride
  • Potassium Sulphate
  • Potassium Nitrate
  • Other Products

Potash End-use Outlook (Volume, Tons; Revenue, USD Million, 2018 - 2032)

  • Agriculture
  • Non-Agriculture

Potash Regional Outlook (Volume, Tons; Revenue, USD Million, 2018 - 2032)

  • North America
    • US.
    • Canada
    • Mexico
  • Europe
    • Spain
    • Italy
    • The Netherlands
    • Germany
    • France
    • UK
    • Belarus
    • Belgium
    • Russia
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Vietnam
    • Malaysia
    • Thailand
    • Australia
  • Central & South America
    • Brazil
    • Argentina
    • Chile
  • Middle East & Africa
    • Morocco
    • Jordan
    • Saudi Arabia
    • South Africa
    • Israel

List of Key Players in Potash Market

  • JSC Belaruskali
  • Compass Minerals Intl. Ltd.
  • Mosaic Company
  • Uralkali
  • Rio Tinto Ltd.
  • BHP Billiton Ltd.
  • Eurochem
  • Red Metal Ltd.
  • Encanto Potash Corp. (EPC)
  • Intrepid Potash Inc.
  • K+S Aktiengesellschaft
  • Nutrien Ltd.

Explore Horizon, the world's most expansive market research database

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Skin Lightening Products Market Soaring Demand Assures Motivated Revenue Share By 2030

 Skin Lightening Products Market Growth & Trends

The global skin lightening products market is expected to reach USD 16.14 billion by 2030, registering a CAGR of 5.5% over the forecast period, according to a new report by Grand View Research, Inc. The growing preference for fair skin to enhance beauty and confidence among consumers is expected to drive global market growth. Furthermore, the rising adoption of skincare regimes to achieve an even skin tone, blemish-free skin, and reduced acne spots is expected to propel the market growth during the forecast period.

The increasing penetration of skin lighteners in the market has increased their application scope among male consumers. The shifting preference toward the skincare regime among male consumers has also influenced the gender to adopt such products to maintain healthy skin. Therefore, manufacturers are increasingly shifting their attention toward the application of such lighteners by men, which is expected to boost the market growth substantially. For instance, Oriflame Cosmetics AG addresses men’s fairness products with its brand North for Men Fairness Face Cream, which is sold across all the regions.

The cleanser segment was valued as the fastest segment in 2021. Rising awareness about skin-related problems caused due to exposure to UV rays will boost the demand for skin lightening cleansers. UV rays expose skin to direct rays from the sun that causes indirect damage to cells' DNA and fasten the process of skin cell aging. Hence, FMCG major companies like Colgate-Palmolive are launching products to keep up the pace with the growing demand among consumers. For instance, in February 2022, Colgate-Palmolive (India) Limited launched Palmolive face wash and scrubs in 3 variants - Anti Acne, Hydrating, and Brightening cleansing range which claims to combine a unique blend of natural ingredients and luxurious essential oils.

Synthetic skin lightening products dominated the market share in 2021. Synthetic products contain raw materials such as sodium lauryl sulfate (SLS), parabens, and petrolatum (petroleum jelly). The inclusion of various chemicals in skin lightening cosmetics as a measure to add preservatives to increase the shelf life boosts the growth of the segment. Some of the brands offering these product variants include Unilever, L'Oréal S.A., WOW, Galderma Laboratories, and others.

Players in this market face intense competition from each other as some of them are among the top manufacturers and have a large customer base for their products in both regional and international markets.

Request a free sample copy or view report summary: Skin Lightening Products Market Report

Skin Lightening Products Market Report Highlights

  • The Asia Pacific is expected to contribute a majority of the share to become the largest division in the global revenue in 2021. The growing market in China, and India is one of the major factors propelling the region to substantial and stable growth.
  • The cleanser segment is projected to register the fastest growth during the forecast period as these products help target a specific area with different skin problems such as skin dullness and pigmentation.
  • Natural segment is predicted to become the fastest-growing segment during the forecast period. Rising consumer awareness regarding the harmful effects of conventional, synthetic chemical-laden products is anticipated to create growth opportunities for these products.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-skin-lightening-products-market

Skin Lightening Products Market Segmentation

Grand View Research has segmented the skin lightening products market based on product, nature, and region.

Skin Lightening Product Outlook (Revenue, USD Million, 2017 - 2030)

  • Creams
  • Cleanser
  • Mask
  • Others

Skin Lightening Products Nature Outlook (Revenue, USD Million, 2017 - 2030)

  • Synthetic
  • Natural
  • Organic

Skin Lightening Products Regional Outlook (Revenue, USD Million, 2017 - 2030)

  • North America
    • US.
  • Europe
    • Germany
    • UK.
  • Asia Pacific
    • China
    • Japan
  • Central & South America
    • Brazil
  • Middle East & Africa

List of Key Players in Skin Lightening Products Market

  • L’Oréal S.A.
  • Beiersdorf AG
  • Shiseido Co., Ltd.
  • Procter & Gamble
  • Unilever
  • Himalaya Global Holdings Ltd.
  • Kanebo Cosmetics Inc.
  • Lotus Herbals Pvt. Ltd.
  • VLCC Health Care Limited
  • Avon Products, Inc.

Explore Horizon, the world's most expansive market research database

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Cultured Food Market To Benefit from Increased Global Uptake of 2024 By 2030

 Cultured Food Market Growth & Trends

The global cultured food market size is expected to reach USD 55.88 billion by 2030, registering a CAGR of 8.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is experiencing significant growth, driven by a convergence of factors that are reshaping consumer preferences and food production practices. Health-conscious consumers seek options that offer both nutritional benefits and promote overall well-being, leading to increased demand for cultured foods, such as yogurt, kefir, and kombucha, which are rich in probiotics and are known for their digestive health benefits. However, concerns about the environmental impact of traditional meat production have spurred interest in alternative protein sources. Cultivated meat and seafood, produced through innovative biotechnological processes, offer a sustainable solution that requires fewer resources and generates fewer emissions compared to conventional animal agriculture.

Manufacturers are embracing collaboration and strategic alliances as essential drivers of innovation in the cultured food sector, enabling them to stay at the forefront of this rapidly evolving industry and meet the evolving demands of consumers for sustainable, ethical, and nutritious food options. For instance, in December 2023, CV Sciences, Inc., a leading consumer wellness company specializing in hemp extracts and other natural ingredients, finalized its acquisition of Cultured Foods, a prominent manufacturer and distributor of plant-based vegan foods. This acquisition presents an opportunity for CV Sciences to import these specialty foods into the U.S. market and establish a European hub for distributing +PlusCBD products, facilitating access to new retail and distributor partners. Moreover, it marks a significant step in CV Sciences' evolution into a diversified global health and wellness enterprise.

Request a free sample copy or view report summary: Cultured Food Market Report

Cultured Food Market Report Highlights

  • The dairy-based cultured food segment accounted for a share of 62.03% in 2023 due to high demand for dairy-based cultured foods, such as yogurt, kefir, and cultured cheeses, on account of their health benefits. These products are rich in probiotics, which support gut health and immunity. As awareness of the importance of gut health grows, consumers are turning to dairy-based cultured foods as a convenient way to incorporate probiotics into their diets
  • The online channels segment is expected to grow at a CAGR of 9.8% from 2024 to 2030. Online platforms provide an opportunity for food manufacturers to educate consumers about the health benefits and nutritional value of cultured foods. Through product descriptions, blog posts, and educational content, consumers can learn more about the importance of probiotics and fermentation in promoting gut health and overall well-being, leading to increased interest and demand for cultured food products
  • Asia Pacific is projected to grow at a CAGR of 9.1% from 2024 to 2030. Many countries in this region have a long history of fermenting foods as part of their traditional culinary practices. For example, kimchi in Korea, miso in Japan, and various fermented dairy products in India have been consumed for centuries. This cultural familiarity with fermented foods has laid the groundwork for the acceptance and popularity of cultured foods in the modern market

Access Press Release@ https://www.grandviewresearch.com/press-release/global-cultured-food-market

Cultured Food Market Segmentation

Grand View Research has segmented the global cultured food market on the basis of product, distribution channel, and region:

Cultured Food Product Outlook (Revenue, USD Billion, 2018 - 2030)

  • Dairy-based
    • Yogurt
    • Kefir
    • Others
  • Plant-based
    • Sauerkraut
    • Kimchi
    • Pickles
    • Miso
    • Tempeh
  • Meat & Seafood
  • Kombucha
  • Others

Cultured Food Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)

  • Supermarkets & Hypermarkets
  • Convenience Stores
  • Online
  • Others

Cultured Food Regional Outlook (Revenue, USD Billion, 2018 - 2030)

  • North America
    • S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Spain
    • Italy
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • South Korea
  • Central & South America
    • Brazil
  • Middle East & Africa
    • South Africa
    • UAE

List of Key Players in the Cultured Food Market

  • UPSIDE Foods
  • Mosa Meat
  • Finless Foods, Inc.
  • BlueNalu
  • Aleph Farms
  • Wildtype
  • Mission Barns
  • Perfect Day, Inc.
  • SuperMeat
  • Shiok Meats Pte. Ltd.
  • Fonterra Co-operative Group Ltd.
  • Danone SA
  • Nestlé SA
  • Lactalis American Group, Inc.
  • Chobani, LLC

Explore Horizon, the world's most expansive market research database

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Missouri Medical Cannabis Market Insights Business Opportunities, Current Trends And Forecast 2030: Grand View Research Inc.

 Missouri Medical Cannabis Market Growth & Trends

The Missouri medical cannabis market size is expected to reach USD 2.0 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 21.4% from 2023 to 2030. Growing evidence of marijuana's health advantages, rising patient knowledge regarding these benefits, and an increase in the prevalence of chronic conditions are the major factors contributing to the market growth. In addition, since November 2018, Missouri has allowed the cultivation, processing, manufacturing, and distribution of medical cannabis. Since then, a sharp rise has been witnessed in the sales of medical cannabis, thereby impelling the growth in the state.

Based on application, the chronic pain segment dominated the market in 2022 with a share of over 25.7% owing to a large patient pool. Pains associated with neurogenic issues, arthritis, low back issues, cancer, headache, neck-related issues, and face-related issues are just a few of the several types of chronic pain. Medical marijuana has been said to help people who are suffering from pain. The market is likely to witness growth during the forecast period as a growing number of people are understanding the importance and benefits of the intake of cannabis-based products.

Based on product, the oils and tinctures segment accounted for the largest revenue share in 2022. Some of the major factors responsible for the segment growth are benefits provided by the utilization of oils and tinctures over smoking flowers and ease of use. In addition, this segment is anticipated to grow at the fastest rate during the forecast period owing to its increasing demand from patients undergoing treatment for health conditions such as PTSD, epilepsy, autism, and chronic pain.

In practically every business, the COVID-19 pandemic has resulted in massive lockdowns, disrupting daily operations and affecting consumer behavior. Retail stores have been closed as the backlash to COVID-19 grows. Due to the suspension of the logistics industry in major raw material-producing countries such as China and India, the market began to experience a supply deficit. Furthermore, supply chain interruptions across the U.S. has led to a tremendous strain on the supply of additional raw materials, thereby constraining the market growth. In addition, this has impacted the manufacturing of cannabis products, and hence the supply chain for medical cannabis in the state has been disrupted.

Request a free sample copy or view report summary: Missouri Medical Cannabis Market Report

Missouri Medical Cannabis Market Report Highlights

  • The legalization of marijuana for medical purposes and the increasing number of people who qualify are likely to bolster the market growth in Missouri
  • Due to factors such as the rising demand for cannabis extracts, the legalization of marijuana for the treatment of various chronic diseases, and new cannabis extract product launches, the oil and tinctures product segment dominated the market in 2021 with a revenue share of over 50.0%
  • By application, chronic pain led the market with a revenue share of over 25.7% in 2022. This is due to a growth in the use of medicinal cannabis as an efficient therapy for acute pain owing to its ability to dull the perceptions and anti-inflammatory qualities

Access Press Release@ https://www.grandviewresearch.com/press-release/missouri-medical-cannabis-market-analysis

Missouri Medical Cannabis Market Segmentation

Grand View Research has segmented the Missouri medical cannabis market based on product and application:

Missouri Medical Cannabis Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Flower
  • Oils & Tinctures

Missouri Medical Cannabis Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Cancer
  • Chronic Pain
  • Depression & Anxiety
  • Arthritis
  • Diabetes
  • Glaucoma
  • Migraines
  • Epilepsy
  • Multiple Sclerosis
  • Others
    • AIDS
    • Amyotrophic Lateral Sclerosis
    • Alzheimer’s
    • Post-Traumatic Stress Disorder (PTSD)
    • Parkinson's
    • Tourette’s
    • Others

List of Key Players of Missouri Medical Cannabis Market

  • BeLeaf Medical
  • Blue Sage Cannabis Co.
  • Show Me Alternatives
  • Heya Wellness
  • Missouri Wild Alchemy
  • Organic Remedies
  • Holistic Industries
  • Kansas City Cannabis
  • LOCAL CANNABIS COMPANY
  • MOcann Extracts

Explore Horizon, the world's most expansive market research database

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Monday, 10 June 2024

Multi-Cloud Management Market to Observe Strong Development by 2030: Grand View Research Inc.

Multi-cloud Management Market Growth & Trends

The global multi-cloud management market size is estimated to reach USD 56.02 billion by 2030, growing at a CAGR of 28.0% from 2023 to 2030, according to a new study by Grand View Research, Inc. The strong emphasis organizations are putting on automation and efficiency, and subsequently on having effective governance processes in place, is expected to drive the adoption of multi-cloud management solutions over the forecast period. Growing concerns over the reliability of a single cloud are also anticipated to play a decisive role in driving the adoption of multi-cloud management solutions. However, concerns over data security and privacy protection coupled with the hardships encountered in redesigning the network for cloud-based infrastructure can restrain the growth of the market.

Independent Software Vendors (ISVs) increasingly rely on virtualization and the cloud as they gradually evolve from software developers to software providers. Cloud-based infrastructure guarantees greater scale, service customization, and flexibility. At this juncture, Cloud Service Providers (CSPs) are also trying aggressively to make a foray into the multi-cloud management industry by adopting, managing, and supporting several cloud products simultaneously. Foraying into the industry would allow CSPs to offer adequate flexibility to ISVs in selecting cloud services according to their changing needs. Concerns over vendor lock-in have discouraged organizations from opting for cloud services. Vendor lock-in can disrupt business operations and force organizations to compromise on performance.

However, organizations have realized that a vendor lock-in situation can be avoided by opting for multiple cloud platforms rather than relying on a single cloud vendor. As a result, single-cloud customers are increasingly adopting multi-cloud management solutions. Advances in technology and the higher levels of flexibility offered by the latest cloud computing technologies are expected to drive industry growth over the forecast period. As such, industry players pursue various strategies, such as product differentiation, launching new products, mergers & acquisitions, and strategic partnerships and collaborations to increase their industry share, cement their position in the market, and expand their business.

For instance, in April 2022, Citrix Systems, Inc. collaborated with Microsoft Corp. to develop a technique for offering an interactive, high-definition experience on various devices. With the help of the Citrix Desktop as a Service (DaaS), IT managers can provide an improved work experience on Cloud PCs by integrating Windows 365 with Citrix Systems’ high-definition user interface technology and ecosystem flexibility. Moreover, employees can seamlessly migrate to Citrix Systems clients through windows365.microsoft.com. Citrix Systems and Microsoft users can have simple access to applications and data.

Request a free sample copy or view the report summary: Multi-cloud Management Market Report

Multi-cloud Management Market Report Highlights

  • The managed services segment is expected to witness significant growth over the forecast period. Managed services allow the users of various cloud platforms, such as AWS, Google Cloud Platform, and Azure, to boost scalability, reduce expenses, and add more agility to their application architecture
  • The small & medium enterprise segment is expected to register the highest CAGR from 2023 to 2030. While SMEs are scouting for business-driven tools and solutions, the increasing number of service providers foraying into the industry offers SMEs several options to choose from, thereby driving the segment’s growth
  • Manufacturing is anticipated to emerge as the fastest-growing segment over the forecast period. Multi-cloud management allows manufacturing entities to distribute their workload across multiple clouds and opt for various deployment models, such as IaaS, PaaS, and SaaS, depending on the application and data
  • Asia Pacific is anticipated to emerge as the fastest-growing region over the forecast period owing to the continued adoption of cloud-based solutions and growing preference for the latest technologies, such as IoTand edge computing

Access Press Release@ https://www.grandviewresearch.com/press-release/global-multi-cloud-management-market

Multi-cloud Management Market Segmentation

Grand View Research has segmented the global multi-cloud management market based on solution, enterprise size, end-use, and region:

Multi-cloud Management Solution Outlook (Revenue, USD Million, 2018 - 2030)

  • Security & Risk Management
  • Training & Consulting
  • Reporting & Analytics
  • Cloud Automation
  • Managed Services
  • Others

Multi-cloud Management Enterprise Size Outlook (Revenue, USD Million, 2018 - 2030)

  • Small & Medium Enterprise (SME)
  • Large Enterprise

Multi-cloud Management End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • BFSI
  • IT & Telecom
  • Consumer Goods & Retail
  • Manufacturing
  • Healthcare
  • Media & Entertainment
  • Government
  • Others

Multi-cloud Management Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • MEA

List of Key Players in the Multi-cloud Management Market

  • BMC Software, Inc.
  • Citrix Systems Inc.
  • CloudBolt Software, Inc.
  • CoreStack
  • Dell Technologies Inc.
  • Flexera Software LLC
  • International Business Machines Corp.
  • Jamcracker Inc.
  • Microsoft Corp.
  • Trianz
  • VMware Inc.

Explore Horizon, the world's most expansive market research database

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Healthcare Payer Services Market Expected to Succeed in CAGR of 7.1% by 2030

 Healthcare Payer Services Market Growth & Trends

The global healthcare payer services market is expected to reach USD 108.0 billion by 2030, registering a CAGR of 7.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The industry is anticipated to witness substantial demand for IT operations so as to allow companies to focus on their core tasks and reduce operational costs. The growing vigilance regarding data security and customer-centricity in projects, especially in the aerospace & defense and BFSI sectors, are fueling the demand for information technology services outsourcing.

The market is progressing owing to the ever-increasing demand for consultancy-related projects. The growing need for proficiency in formulating and streamlining IT strategy, enterprise architecture advisory, portfolio consulting, and ensuring effective and smooth digital transformation further boosts the industry growth. Rapid innovations, offering various benefits to different industries globally, will also support market growth. Delegation of time-consuming and tedious tasks to service providers empowers businesses to concentrate on their central functionalities and reduces the load on their internal resources. It also offers optimization of capacity, resources, and flexibility to meet the demands of the changing commercial environment, and better access to innovation and intellectual property.

Service providers are coming up with different operational and pricing models to gain a competitive edge over others. The advent of cloud computing has fueled market growth as it enables firms to automate and ease their business applications and processes. Hence, enterprises, especially Small & Medium Businesses (SMBs), are largely deploying the Software as a Service (SaaS) model and the Infrastructure as a Service (IaaS) model, which has compelled the service providers to capitalize on the cloud-based offerings.

The COVID-19 pandemic has impacted the healthcare payer services market significantly. The market is doing well financially as compared to other sectors due to a rise in demand for medical care. However, the coming years for the economics of the market are full of threats. However, the payers are doing their part in this pandemic by providing support to providers, helping in the management and delivery of COVID-19 related supplies to multiple care providers, and also creating web portals that provide relevant and rapid information related to COVID-19.

Request a free sample copy or view report summary: Healthcare Payer Services Market Report

Healthcare Payer Services Market Report Highlights

  • ITO services segment dominated the market with the largest revenue share in 2023. The rising demand for advanced and innovative technologies, increased investment in Artificial Intelligence (AI) technology, and growing engagement in healthcare decisions are the key factors driving the market growth of this segment.
  • The claims management services segment dominated the market with the largest revenue share in 2023. The presence of ACA and increasing overall healthcare expenditure are crucial factors driving the number of members enrolled in the Centers for Medicare and Medicaid Services.
  • The public payers segment is expected to emerge as the fastest growing, with a CAGR of 7.3% over the estimated timeline.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-healthcare-payer-services-market

Healthcare Payer Services Market Segmentation

Grand View Research has segmented the global healthcare payer services market report based on services, application, end-use, and region:

Healthcare Payer Services Service Outlook (Revenue, USD Billion, 2018 - 2030)

  • BPO Services
  • ITO Services
  • KPO Services

Healthcare Payer Services Application Outlook (Revenue, USD Billion, 2018 - 2030)

  • Claims Management Services
  • Integrated Front Office Service and Back Office Operations
  • Member Management Services
  • Provider Management Services
  • Billing and Accounts Management Services
  • Analytics and Fraud Management Services
  • HR Services

Healthcare Payer Services End-use Outlook (Revenue, USD Billion, 2018 - 2030)

  • Private Payers
  • Public Payers

Healthcare Payer Services Regional Outlook (Revenue, USD Billion, 2018 - 2030)

  • North America
    • US.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Norway
    • Denmark
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Kuwait

List Of Key Players in the Healthcare Payer Services Market

  • Cognizant
  • EXL
  • HGS Ltd. (Hinduja Global Solutions Limited)
  • Accenture
  • Xerox Corporation
  • Concentric Corporation
  • Genpact
  • WIPRO Ltd.
  • HCL Technologies

Explore Horizon, the world's most expansive market research database

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Fetal Monitoring Equipment Market is Thriving $6.16 Billion Revenue by 2030: Grand View Research Inc.

  Fetal Monitoring Equipment Market Growth & Trends The global  fetal monitoring equipment market  size is anticipated to reach USD 6.16...